Velina Nedkova-Hristova

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Denny J. Padgett, Adam L. Comer, Yi-Chung Lee, 2023, The Lancet Neurology.

Genotype–phenotype correlations in valosin-containing protein disease: a retrospective muticentre study

Sruthi S. Nair, K. Claeys, E. Malfatti, 2022, Journal of Neurology, Neurosurgery, and Psychiatry.